NCT04809766: Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma |
|
|
| Recruiting | 1 | 15 | US | Autologous Mesothelin-specific TCR-T Cells, Cyclophosphamide, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane, 6055-19-2, Fludarabine, Fluradosa, 21679-14-1, Bendamustine, SDX-105, 16506-27-7 | Fred Hutchinson Cancer Center, Lonza Walkersville, Inc. | Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | 06/24 | 06/25 | | |
